Brief: China Nt Pharma Group Co Fy Net Profit Attributable RMB 165.2 Mln VS RMB 116.2 Mln
26/03/2018 23:17
March 27 (Reuters) - China Nt Pharma Group Co Ltd 1011.HK :
* FY REVENUE RMB604.8 MILLION VERSUS RMB359.6 MILLION
* FY NET PROFIT ATTRIBUTABLE RMB165.2 MILLION VERSUS
RMB116.2
MILLION
* FINAL DIVIDEND OF HK3.5 CENTS PER SHARE
Source text for Eikon: ID:nHKS1C5LtC
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY